Medindia

X

Pharmaco in Zambia Scrutinizes the Side Effects of Medicines Launched In the Market

by Medindia Content Team on  June 18, 2006 at 11:19 AM Corporate News   - G J E 4
Pharmaco in Zambia Scrutinizes the Side Effects of Medicines Launched In the Market
A new vigilant body was set up by the Zambia Pharmaceutical Regulatory Authority (PRA). The main purpose of this body is to monitor the safety of medicines during the post marketing surveillance process. Pharmaco, as the monitoring body is named would supervise all adverse reactions due to a particular drug. This is to inculcate in people the rational use of medicines. The acting Health Minister Ronnie Shikapwasha launched the body on the 16th of June said that this unit would efficiently perform the job allotted to it. He also said that this was launched as adverse effects of all drugs that hit the market are not known before the medicine is marketed.
Advertisement

Hence this body would create awareness among he public. He said that in the recent years there was an increase in the use of medicine for HIV/AIDS, malaria and tuberculosis and hence there was a need for the monitoring unit. These drugs were new to the market and sufficient safety data was not available. This led to the development of a monitoring system which would study the effects of the drugs, documenting drug resistance patterns and treatment failures of both conventional and new medicines. In conclusion this would always keep the public as well as the medical community posted about the medicines in the market.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: